{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:56:59Z","timestamp":1775728619489,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.brachy.2021.05.165","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T09:43:15Z","timestamp":1627033395000},"page":"1226-1234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Outcomes for posterior uveal melanoma: Validation of American Brachytherapy Society Guidelines"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2107-7168","authenticated-orcid":false,"given":"Kyle","family":"Meidenbauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2079-4656","authenticated-orcid":false,"given":"Renato J.","family":"Yupari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7592-0480","authenticated-orcid":false,"given":"James F.","family":"Bena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun D.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2021.05.165_bib0001","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013)","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0002","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000504312","article-title":"Practice patterns for the treatment of uveal melanoma with Iodine-125 plaque brachytherapy: ocular oncology study consortium report 5","volume":"6","author":"Binder","year":"2020","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0003","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0197-2456(93)90052-F","article-title":"Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study","volume":"14","author":"Group","year":"1993","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.brachy.2021.05.165_bib0004","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2021.05.165_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"American Brachytherapy Society - Ophthalmic Oncology Task Force. Electronic address pec, Committee AO. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2021.05.165_bib0006","article-title":"Small choroidal melanoma: outcomes following apical height dose brachytherapy","author":"Yupari","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0007","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamaophthalmol.2014.5395","article-title":"International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal Melanoma","volume":"133","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(97)00088-X","article-title":"Radiation therapy for choroidal melanoma","volume":"42","author":"Finger","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0009","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0161-6420(99)90124-0","article-title":"Palladium-103 plaque radiotherapy for choroidal melanoma: Results of a 7-year study","volume":"106","author":"Finger","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2021.05.165_bib0010","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.118.9.1219","article-title":"Plaque Radiotherapy for Uveal Melanoma: Long-term Visual Outcome in 1106 Consecutive Patients","volume":"118","author":"Shields","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0011","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2021.05.165_bib0012","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijrobp.2005.02.017","article-title":"Local tumor control after 106Ru brachytherapy of choroidal melanoma","volume":"63","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.05.165_bib0013","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.radonc.2010.03.023","article-title":"Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma","volume":"95","author":"Verschueren","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/517032","article-title":"Long-term followup comparing two treatment dosing strategies of (125) I plaque radiotherapy in the management of small\/medium posterior uveal melanoma","volume":"2013","author":"Murray","year":"2013","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajo.2017.05.019","article-title":"Pattern of local recurrence after I-125 episcleral brachytherapy for uveal melanoma in a Spanish referral ocular oncology unit","volume":"180","author":"Sanchez-Tabernero","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0016","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/IAE.0000000000002113","article-title":"Relationship of clinical features and baseline tumor size with gene expression profile status in uveal melanoma: a multi-institutional study","volume":"39","author":"Berry","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.brachy.2021.05.165_bib0017","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13014-020-01621-4","article-title":"106Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma","volume":"15","author":"Jiang","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0018","doi-asserted-by":"crossref","first-page":"381","DOI":"10.21873\/invivo.11784","article-title":"AVATAR: analysis for visual acuity prediction after eye interventional radiotherapy","volume":"34","author":"Pagliara","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.brachy.2021.05.165_bib0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajo.2017.01.024","article-title":"Local failure after episcleral brachytherapy for posterior uveal melanoma: patterns, risk factors, and management","volume":"177","author":"Bellerive","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jamaophthalmol.2016.0104","article-title":"Vision loss following episcleral brachytherapy for uveal melanoma: development of a vision prognostication tool","volume":"134","author":"Aziz","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0021","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jamaophthalmol.2019.5122","article-title":"Studies evaluating visual outcomes after brachytherapy in uveal melanoma\u2014Strengths and limitations of current investigations","volume":"138","author":"Boldt","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0022","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archophthalmol.2010.166","article-title":"Mortality after diagnosis of small melanocytic lesions of the choroid","volume":"128","author":"Lane","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0023","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaophthalmol.2018.3881","article-title":"Visual outcome and millimeter incremental risk of metastasis in 1780 patients with small choroidal melanoma managed by plaque radiotherapy","volume":"136","author":"Shields","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0024","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archopht.1987.01060060049030","article-title":"Selection of iodine 125 for the collaborative ocular melanoma study","volume":"105","author":"Earle","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0025","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2021.05.165_bib0026","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jamaophthalmol.2015.4810","article-title":"Hepatic ultrasonography for surveillance in patients with uveal melanoma","volume":"134","author":"Choudhary","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0027","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archopht.1997.01100160056009","article-title":"Mortality in patients with small choroidal melanoma. COMS report no. 4. The Collaborative Ocular Melanoma Study Group","volume":"115","author":"Group","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0028","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.2012.45.2771","article-title":"Staging of ciliary body and choroidal melanomas based on anatomic extent","volume":"31","author":"Kujala","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0029","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jamaophthalmol.2020.5720","article-title":"Estimating cured fractions of uveal melanoma","volume":"139","author":"Singh","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.brachy.2021.05.165_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ophtha.2015.09.014","article-title":"Local recurrence significantly increases the risk of metastatic uveal melanoma","volume":"123","author":"Gallie","year":"2016","journal-title":"Ophthalmology"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472121004414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472121004414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:18:32Z","timestamp":1761531512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472121004414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1538472121004414"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2021.05.165","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes for posterior uveal melanoma: Validation of American Brachytherapy Society Guidelines","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2021.05.165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}